Dietary fat and hormonal effects on erythrocyte membrane fluidity and lipid composition in adult women.
Erythrocyte ghost membrane fluidity and phospholipid linoleate were significantly increased when higher levels of polyunsaturated fats were fed to healthy, free living, premenopausal women. Fluidity was assessed by diphenylhexatriene (DPH) fluorescence polarization measurements with hypotonically lysed red blood cells from 31 female subjects fed one of two sets of diets, which were formulated from typical US foods to contain polyunsaturate to saturate ratios (P/S) of 1.0 or 0.3. Both groups of women were fed diets with 40% of energy as fat for four menstrual cycles followed by low-fat diets having 20% of energy as fat for the next four menstrual cycles. Blood was sampled during the fourth cycle of each dietary period at times estimated to correspond to maximum secretions of estrogen and progesterone to assess interactive hormonal and dietary effects on membrane composition and fluidity. Red blood cell membranes were most fluid following higher levels of linoleate intake, either by higher (40%) total fat or higher P/S levels. Membrane fluidity was directly related to the phospholipid oleate and linoleate contents and inversely related to the molar cholesterol/phospholipid ratio. Hormonal status effects on the membranes were not extensive. Membrane fluidity in cells from women fed P/S = 0.3 diets was higher at 40% than at 20% fat during the luteal phase of the fourth cycle. In contrast, women fed the P/S = 1.0 diets had more fluid red cells at 40% fat during the follicular phase of the cycle. Regression analysis showed a direct linear correlation between membrane fluidity and red cell membrane insulin binding demonstrating a relation between receptor binding and cell membrane fluidity in the human female.
Lipid and Carbohydrate Nutrition Laboratories, Beltsville Human Nutrition Research Center, MD 20705.
E
E
Berlin
S J
SJ
Bhathena
J T
JT
Judd
P P
PP
Nair
D Y
DY
Jones
P R
PR
Taylor
D000328:Adult; D002784:Cholesterol / Q000097:blood; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D004161:Diphenylhexatriene; D004910:Erythrocyte Membrane / Q000502:physiology*; D004967:Estrogens / Q000502:physiology*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D005454:Fluorescence Polarization; D005456:Fluorescent Dyes; D005498:Follicular Phase; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000008:administration & dosage; D008183:Luteal Phase; D008560:Membrane Fluidity; D008563:Membrane Lipids / Q000097:blood*; D008597:Menstrual Cycle; D019301:Oleic Acid; D009829:Oleic Acids / Q000008:administration & dosage; D010743:Phospholipids / Q000097:blood; D011374:Progesterone / Q000502:physiology*; D012044:Regression Analysis
D004041:Dietary Fats; D004967:Estrogens; D005227:Fatty Acids; D005456:Fluorescent Dyes; D008041:Linoleic Acids; D008563:Membrane Lipids; D009829:Oleic Acids; D010743:Phospholipids; D004161:Diphenylhexatriene; D019301:Oleic Acid; D011374:Progesterone; D002784:Cholesterol; D019787:Linoleic Acid